Clinical Trials - VTVT

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06334133Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesRECRUITINGPHASE32024-06-142026-102026-09
NCT03980730Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose ToleranceTERMINATEDPHASE22019-06-272021-01-292020-12-01
NCT03335371Evaluation of TTP399 in Patients With Type 1 DiabetesCOMPLETEDPHASE1, PHASE22017-10-252020-01-062019-12-20
NCT029160562-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)TERMINATEDPHASE32016-122018-06-012018-06-01
NCT02653599A Study to Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 DiabetesCOMPLETEDPHASE22015-122017-012016-11
NCT02080364Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's DiseaseTERMINATEDPHASE32015-042018-06-012018-06-01
NCT02405260Add Glucokinase Activator to Target A1cCOMPLETEDPHASE22015-032016-092016-07
NCT01665352A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 DiabetesCOMPLETEDPHASE22012-082013-052013-05
NCT01474083A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 DiabetesCOMPLETEDPHASE1, PHASE22011-112012-092012-08
NCT01548430A Safety Study of TTP4000 in Subjects With Alzheimer's DiseaseCOMPLETEDPHASE12011-102013-022013-02
NCT00909298Left Ventricular Assist Device (LVAD) Specialized Centers of Clinically Orientated Research (SCCOR) Coagulation - Acute Intrinsic Pathway Antagonist (IPA)TERMINATEDPHASE22009-062010-06
NCT00779519Safety Study of the Inhibition of Agouti-related Protein (AgRP) for the Management of Obesity and Weight LossCOMPLETEDPHASE22009-022009-12
NCT00119457Factor IX Inhibition in Thrombosis Prevention (The FIXIT Trial)COMPLETEDPHASE22005-012006-04